Disposal

MDGH GMTN (RSC) Ltd
04 March 2025
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018

 

Mamoura Diversified Global Holding PJSC ("MDGH") - Sale of shareholding by Nova Chemicals Holding GmbH to Abu Dhabi National Oil Company (ADNOC) PJSC

 

Nova Chemicals Holding GmbH, an indirect wholly owned subsidiary of MDGH, has entered into an agreement to sell its interest in the entire issued share capital of NOVA Chemicals Corporation to Abu Dhabi National Oil Company (ADNOC) PJSC for a total consideration of $13.4 billion including debt, the completion of which is subject to customary closing conditions and regulatory approvals.

 

For further information, please contact:

Mamoura Diversified Global Holding PJSC

P.O. Box 45005, Abu Dhabi, United Arab Emirates

 

Telephone:     +971 2 413 0000

Fax:                 +971 2 413 0001

Email:              ir@mubadala.ae (for investor relations queries)

media@mubadala.ae (for media queries)

 

This announcement is released by MDGH GMTN (RSC) Ltd and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (UK MAR), encompassing information relating to the Global Medium Term Note Programme established by MDGH GMTN (RSC) Ltd and unconditionally and irrevocably guaranteed by Mamoura Diversified Global Holding PJSC. For the purposes of UK MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, this announcement is made by Abdulla Mubarak Abdulla Mubarak Al Darmaki as director of MDGH GMTN (RSC) Ltd.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings